Drugs.com FDA MedWatch AlertsOriginal article
Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter
RegulatoryDexmedetomidine HCl in 0.9% Sodium Chloride InjectionNegative
AI Analysis
Summary
Par Health voluntarily recalled two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection (400 mcg/100 mL) due to presence of particulate matter. The recall was issued at the hospital level on September 18, 2026.
Outcome Details
Voluntary recall of two lots due to presence of particulate matter
Importance:4/10
Sentiment:
-0.70
recallproduct_safetyquality_issueparticulate_matter
Read the original article
Published by Drugs.com FDA MedWatch Alerts on September 18, 2026 10:35 AM